The global Migraine With Brainstem Aura Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occur in men and women of all ages.
This report aims to provide a comprehensive presentation of the global market for Migraine With Brainstem Aura Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine With Brainstem Aura Drugs.
This report contains market size and forecasts of Migraine With Brainstem Aura Drugs in global, including the following market information:
Global Migraine With Brainstem Aura Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
Geographically, the Americas is anticipated to dominate the global migraine with brainstem aura market owing to a well-developed healthcare sector, rising prevalence of migraine and growing healthcare expenditure.
We surveyed the Migraine With Brainstem Aura Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine With Brainstem Aura Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, by Type, 2022 (%)
- Abortive Medication
- Preventive Medication
Global Migraine With Brainstem Aura Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, by Application, 2022 (%)
- Retail Pharmacies
- Hospital Pharmacies
- Others
Global Migraine With Brainstem Aura Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Migraine With Brainstem Aura Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Migraine With Brainstem Aura Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- GlaxoSmithKline
- Abbott Laboratories
- Eli Lily
- Johnson & Johnson
- AstraZeneca
- Eisai
- Allergen
- Merck
- Endo International
- Impax Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Migraine With Brainstem Aura Drugs, market overview.
Chapter 2: Global Migraine With Brainstem Aura Drugs market size in revenue.
Chapter 3: Detailed analysis of Migraine With Brainstem Aura Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Migraine With Brainstem Aura Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Migraine With Brainstem Aura Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Migraine With Brainstem Aura Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Migraine With Brainstem Aura Drugs Overall Market Size
2.1 Global Migraine With Brainstem Aura Drugs Market Size: 2022 VS 2030
2.2 Global Migraine With Brainstem Aura Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Migraine With Brainstem Aura Drugs Players in Global Market
3.2 Top Global Migraine With Brainstem Aura Drugs Companies Ranked by Revenue
3.3 Global Migraine With Brainstem Aura Drugs Revenue by Companies
3.4 Top 3 and Top 5 Migraine With Brainstem Aura Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Migraine With Brainstem Aura Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Migraine With Brainstem Aura Drugs Players in Global Market
3.6.1 List of Global Tier 1 Migraine With Brainstem Aura Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Migraine With Brainstem Aura Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Migraine With Brainstem Aura Drugs Market Size Markets, 2022 & 2030
4.1.2 Abortive Medication
4.1.3 Preventive Medication
4.2 By Type - Global Migraine With Brainstem Aura Drugs Revenue & Forecasts
4.2.1 By Type - Global Migraine With Brainstem Aura Drugs Revenue, 2018-2023
4.2.2 By Type - Global Migraine With Brainstem Aura Drugs Revenue, 2024-2030
4.2.3 By Type - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Migraine With Brainstem Aura Drugs Market Size, 2022 & 2030
5.1.2 Retail Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Others
5.2 By Application - Global Migraine With Brainstem Aura Drugs Revenue & Forecasts
5.2.1 By Application - Global Migraine With Brainstem Aura Drugs Revenue, 2018-2023
5.2.2 By Application - Global Migraine With Brainstem Aura Drugs Revenue, 2024-2030
5.2.3 By Application - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Migraine With Brainstem Aura Drugs Market Size, 2022 & 2030
6.2 By Region - Global Migraine With Brainstem Aura Drugs Revenue & Forecasts
6.2.1 By Region - Global Migraine With Brainstem Aura Drugs Revenue, 2018-2023
6.2.2 By Region - Global Migraine With Brainstem Aura Drugs Revenue, 2024-2030
6.2.3 By Region - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Migraine With Brainstem Aura Drugs Revenue, 2018-2030
6.3.2 US Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.3.3 Canada Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.3.4 Mexico Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Migraine With Brainstem Aura Drugs Revenue, 2018-2030
6.4.2 Germany Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.4.3 France Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.4.4 U.K. Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.4.5 Italy Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.4.6 Russia Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.4.8 Benelux Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Migraine With Brainstem Aura Drugs Revenue, 2018-2030
6.5.2 China Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.5.3 Japan Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.5.4 South Korea Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.5.6 India Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Migraine With Brainstem Aura Drugs Revenue, 2018-2030
6.6.2 Brazil Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.6.3 Argentina Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Migraine With Brainstem Aura Drugs Revenue, 2018-2030
6.7.2 Turkey Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.7.3 Israel Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Migraine With Brainstem Aura Drugs Market Size, 2018-2030
6.7.5 UAE Migraine With Brainstem Aura Drugs Market Size, 2018-2030
7 Migraine With Brainstem Aura Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Migraine With Brainstem Aura Drugs Major Product Offerings
7.1.4 Pfizer Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Migraine With Brainstem Aura Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Migraine With Brainstem Aura Drugs Major Product Offerings
7.3.4 Abbott Laboratories Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.3.5 Abbott Laboratories Key News & Latest Developments
7.4 Eli Lily
7.4.1 Eli Lily Company Summary
7.4.2 Eli Lily Business Overview
7.4.3 Eli Lily Migraine With Brainstem Aura Drugs Major Product Offerings
7.4.4 Eli Lily Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.4.5 Eli Lily Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Migraine With Brainstem Aura Drugs Major Product Offerings
7.5.4 Johnson & Johnson Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Migraine With Brainstem Aura Drugs Major Product Offerings
7.6.4 AstraZeneca Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Eisai
7.7.1 Eisai Company Summary
7.7.2 Eisai Business Overview
7.7.3 Eisai Migraine With Brainstem Aura Drugs Major Product Offerings
7.7.4 Eisai Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.7.5 Eisai Key News & Latest Developments
7.8 Allergen
7.8.1 Allergen Company Summary
7.8.2 Allergen Business Overview
7.8.3 Allergen Migraine With Brainstem Aura Drugs Major Product Offerings
7.8.4 Allergen Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.8.5 Allergen Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Migraine With Brainstem Aura Drugs Major Product Offerings
7.9.4 Merck Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 Endo International
7.10.1 Endo International Company Summary
7.10.2 Endo International Business Overview
7.10.3 Endo International Migraine With Brainstem Aura Drugs Major Product Offerings
7.10.4 Endo International Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.10.5 Endo International Key News & Latest Developments
7.11 Impax Laboratories
7.11.1 Impax Laboratories Company Summary
7.11.2 Impax Laboratories Business Overview
7.11.3 Impax Laboratories Migraine With Brainstem Aura Drugs Major Product Offerings
7.11.4 Impax Laboratories Migraine With Brainstem Aura Drugs Revenue in Global Market (2018-2023)
7.11.5 Impax Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Migraine With Brainstem Aura Drugs Market Opportunities & Trends in Global Market
Table 2. Migraine With Brainstem Aura Drugs Market Drivers in Global Market
Table 3. Migraine With Brainstem Aura Drugs Market Restraints in Global Market
Table 4. Key Players of Migraine With Brainstem Aura Drugs in Global Market
Table 5. Top Migraine With Brainstem Aura Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Migraine With Brainstem Aura Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Migraine With Brainstem Aura Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Migraine With Brainstem Aura Drugs Product Type
Table 9. List of Global Tier 1 Migraine With Brainstem Aura Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Migraine With Brainstem Aura Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Migraine With Brainstem Aura Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Migraine With Brainstem Aura Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Migraine With Brainstem Aura Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Migraine With Brainstem Aura Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Migraine With Brainstem Aura Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Migraine With Brainstem Aura Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Migraine With Brainstem Aura Drugs Product Offerings
Table 32. Pfizer Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Migraine With Brainstem Aura Drugs Product Offerings
Table 36. GlaxoSmithKline Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. Abbott Laboratories Company Summary
Table 39. Abbott Laboratories Migraine With Brainstem Aura Drugs Product Offerings
Table 40. Abbott Laboratories Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Laboratories Key News & Latest Developments
Table 42. Eli Lily Company Summary
Table 43. Eli Lily Migraine With Brainstem Aura Drugs Product Offerings
Table 44. Eli Lily Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Eli Lily Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Migraine With Brainstem Aura Drugs Product Offerings
Table 48. Johnson & Johnson Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Migraine With Brainstem Aura Drugs Product Offerings
Table 52. AstraZeneca Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Eisai Company Summary
Table 55. Eisai Migraine With Brainstem Aura Drugs Product Offerings
Table 56. Eisai Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Eisai Key News & Latest Developments
Table 58. Allergen Company Summary
Table 59. Allergen Migraine With Brainstem Aura Drugs Product Offerings
Table 60. Allergen Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Allergen Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Migraine With Brainstem Aura Drugs Product Offerings
Table 64. Merck Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Endo International Company Summary
Table 67. Endo International Migraine With Brainstem Aura Drugs Product Offerings
Table 68. Endo International Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Endo International Key News & Latest Developments
Table 70. Impax Laboratories Company Summary
Table 71. Impax Laboratories Migraine With Brainstem Aura Drugs Product Offerings
Table 72. Impax Laboratories Migraine With Brainstem Aura Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Impax Laboratories Key News & Latest Developments
List of Figures
Figure 1. Migraine With Brainstem Aura Drugs Segment by Type in 2022
Figure 2. Migraine With Brainstem Aura Drugs Segment by Application in 2022
Figure 3. Global Migraine With Brainstem Aura Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Migraine With Brainstem Aura Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Migraine With Brainstem Aura Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Migraine With Brainstem Aura Drugs Revenue in 2022
Figure 8. By Type - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 16. US Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 28. China Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Migraine With Brainstem Aura Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Laboratories Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli Lily Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Eisai Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Allergen Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Endo International Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Impax Laboratories Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
